BDBM275912 US10071974, Example 23::US10071974, Example 24::US10071974, Example 25::US10577336, Example 25

SMILES Cn1nc(c2ccccc12)C(C)(C)NC(=O)C1CNCCCO1

InChI Key InChIKey=GWOJVVDZCRLEDR-UHFFFAOYSA-N

Data  10 KI  6 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 16 hits for monomerid = 275912   

TargetSomatostatin receptor type 4(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataKi:  522nM ΔG°:  -8.56kcal/moleT: 2°CAssay Description:For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataKi:  522nMAssay Description:Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataKi:  8.62E+3nMAssay Description:Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataKi:  8.62E+3nM ΔG°:  -6.90kcal/moleT: 2°CAssay Description:For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataKi:  9.45E+3nM ΔG°:  -6.85kcal/moleT: 2°CAssay Description:For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataKi:  9.45E+3nMAssay Description:Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataKi:  9.60E+3nMAssay Description:Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataKi:  9.60E+3nM ΔG°:  -6.84kcal/moleT: 2°CAssay Description:For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataKi:  9.75E+3nM ΔG°:  -6.83kcal/moleT: 2°CAssay Description:For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataKi:  9.75E+3nMAssay Description:Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataEC50:  36.5nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataEC50:  36.2nMAssay Description:The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataEC50:  36.5nMAssay Description:The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataEC50:  1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataEC50:  36.2nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM275912(US10071974, Example 23 | US10071974, Example 24 | ...)
Affinity DataEC50:  1.00E+3nMAssay Description:The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent